Unichem Laboratories Balance Sheet Health
Financial Health criteria checks 5/6
Unichem Laboratories has a total shareholder equity of ₹24.0B and total debt of ₹2.7B, which brings its debt-to-equity ratio to 11.2%. Its total assets and total liabilities are ₹33.1B and ₹9.1B respectively. Unichem Laboratories's EBIT is ₹526.1M making its interest coverage ratio 3. It has cash and short-term investments of ₹2.0B.
Key information
11.2%
Debt to equity ratio
₹2.68b
Debt
| Interest coverage ratio | 3x |
| Cash | ₹1.98b |
| Equity | ₹24.01b |
| Total liabilities | ₹9.10b |
| Total assets | ₹33.11b |
Recent financial health updates
Is Unichem Laboratories (NSE:UNICHEMLAB) Using Debt Sensibly?
Feb 01
Does Unichem Laboratories (NSE:UNICHEMLAB) Have A Healthy Balance Sheet?
Sep 06Unichem Laboratories (NSE:UNICHEMLAB) Is Making Moderate Use Of Debt
Nov 27Is Unichem Laboratories (NSE:UNICHEMLAB) Weighed On By Its Debt Load?
Dec 10Is Unichem Laboratories (NSE:UNICHEMLAB) Using Too Much Debt?
Aug 26
Recent updates
Revenues Tell The Story For Unichem Laboratories Limited (NSE:UNICHEMLAB) As Its Stock Soars 26%
Nov 02It's A Story Of Risk Vs Reward With Unichem Laboratories Limited (NSE:UNICHEMLAB)
Sep 13Optimistic Investors Push Unichem Laboratories Limited (NSE:UNICHEMLAB) Shares Up 26% But Growth Is Lacking
Feb 06Is Unichem Laboratories (NSE:UNICHEMLAB) Using Debt Sensibly?
Feb 01Does Unichem Laboratories (NSE:UNICHEMLAB) Have A Healthy Balance Sheet?
Sep 06Unichem Laboratories (NSE:UNICHEMLAB) Is Due To Pay A Dividend Of ₹4.00
Jul 30There's Reason For Concern Over Unichem Laboratories Limited's (NSE:UNICHEMLAB) Massive 28% Price Jump
Jul 23Unichem Laboratories (NSE:UNICHEMLAB) Will Pay A Dividend Of ₹4.00
Jul 15Unichem Laboratories (NSE:UNICHEMLAB) Will Pay A Dividend Of ₹4.00
Jul 01Unichem Laboratories (NSE:UNICHEMLAB) Is Making Moderate Use Of Debt
Nov 27Investors Shouldn't Be Too Comfortable With Unichem Laboratories' (NSE:UNICHEMLAB) Robust Earnings
Jun 05Should Unichem Laboratories Limited (NSE:UNICHEMLAB) Be Part Of Your Income Portfolio?
Mar 02Unichem Laboratories Limited's (NSE:UNICHEMLAB) Stock's Been Going Strong: Could Weak Financials Mean The Market Will Correct Its Share Price?
Feb 09Should You Take Comfort From Insider Transactions At Unichem Laboratories Limited (NSE:UNICHEMLAB)?
Jan 19Do Institutions Own Unichem Laboratories Limited (NSE:UNICHEMLAB) Shares?
Dec 29Is Unichem Laboratories (NSE:UNICHEMLAB) Weighed On By Its Debt Load?
Dec 10Key Things To Understand About Unichem Laboratories' (NSE:UNICHEMLAB) CEO Pay Cheque
Nov 23Did Unichem Laboratories' (NSE:UNICHEMLAB) Share Price Deserve to Gain 41%?
Nov 02Should You Buy Unichem Laboratories Limited (NSE:UNICHEMLAB) For Its 1.5% Dividend?
Oct 13How Much Are Unichem Laboratories Limited (NSE:UNICHEMLAB) Insiders Spending On Buying Shares?
Sep 16Is Unichem Laboratories (NSE:UNICHEMLAB) Using Too Much Debt?
Aug 26Is Unichem Laboratories Limited's (NSE:UNICHEMLAB) Shareholder Ownership Skewed Towards Insiders?
Aug 05Would Shareholders Who Purchased Unichem Laboratories'(NSE:UNICHEMLAB) Stock Three Years Be Happy With The Share price Today?
Jul 14Financial Position Analysis
Short Term Liabilities: UNICHEMLAB's short term assets (₹18.3B) exceed its short term liabilities (₹8.2B).
Long Term Liabilities: UNICHEMLAB's short term assets (₹18.3B) exceed its long term liabilities (₹907.1M).
Debt to Equity History and Analysis
Debt Level: UNICHEMLAB's net debt to equity ratio (2.9%) is considered satisfactory.
Reducing Debt: UNICHEMLAB's debt to equity ratio has increased from 7.3% to 11.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable UNICHEMLAB has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: UNICHEMLAB is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 33.6% per year.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/03 19:12 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Unichem Laboratories Limited is covered by 13 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Rakesh Nayudu | Almondz Global Securities Ltd |
| Sriraam Rathi | Anand Rathi Shares and Stock Brokers Limited |
| null null | Anand Rathi Shares and Stock Brokers Limited |